ClinicalTrials.gg
RecruitingNCT07177430Updated Dec 5, 2025

Inspiratory Muscle Training in Children and Adolescents With Idiopathic Scoliosis Undergoing Schroth Therapy.

An interventional study of Inspiratory Muscle Training and Inspiratory Muscle Training (Sham) in Scoliosis Idiopathic, sponsored by Wroclaw University of Health and Sport Sciences. Recruiting at 2 sites in Poland. Open to participants aged 11 Years to 16 Years. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by Wroclaw University of Health and Sport Sciences · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Oct 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
11 Years to 16 Years
Sex
All
01

Study summary

This study evaluates the effectiveness of inspiratory muscle training in children and adolescents with idiopathic scoliosis undergoing therapy with the Schroth method.

The intervention- inspiratory muscle training- aims to improve respiratory function, increase exercise tolerance, and strengthen core stability in the participants.

The proposed training may enhance the effectiveness of therapy conducted using the Schroth method and improve participants' performance in activities of daily living.

The project aims to assess the impact of inspiratory muscle training in children and adolescents with idiopathic scoliosis on respiratory system function, exercise tolerance, and core stability.

02

Conditions studied

  • Scoliosis Idiopathic

Keywords

  • Inspiratory Muscle Training
  • Schroth method
  • Exercise tolerance
  • Core stability
  • Respiratory function
03

In context

Lead sponsor

Wroclaw University of Health and Sport Sciences is the lead sponsor of 47 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosed idiopathic scoliosis,
  • age: 11-16 years (girls after their first period, boys after voice mutation),
  • spinal curvature angle > 20° according to Cobb,
  • guardian's consent to participate in the study;

Exclusion criteria

Exclusion Criteria:

  • chronic respiratory diseases,
  • inhalant allergies,
  • limited contact with the patient, preventing the examination from being performed;
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
56 participants (estimated)

Study arms

  • Sham comparator
    Sham Group

    IMT (Sham) and Schroth therapy

    Device: Inspiratory Muscle Training (Sham)

  • Experimental
    IMT Group

    IMT and Schroth therapy

    Device: Inspiratory Muscle Training

Interventions

  • DeviceInspiratory Muscle Training

    Participants will perform inspiratory muscle training using a respiratory muscle trainer. The initial training load will be set at 30% of PImax. The intervention will last for 8 weeks and will be carried out 5 days per week, twice daily, in 3 sets of 10 repetitions. The training load will be increased in the 2nd, 4th, and 6th week of the program, each time by an additional 10% relative to the initial PImax.

  • DeviceInspiratory Muscle Training (Sham)

    The training intervention in the Sham Group will differ from the experimental group only in terms of training load. This load will remain constant at 15% PImax, which does not cause any changes in the functioning of the inspiratory muscles. All other training parameters will be identical to those in the IMT group.

06

What researchers measure

Primary outcomes

  1. Pulmonary function test

    Assessment of pulmonary ventilation will be performed using pulmonary function testing with a MasterScreen Pneumo spirometer (Jaeger). This examination is non-invasive and performed in accordance with ATS and ERS criteria. The data collected for analysis will include the following parameters: vital capacity (VC), forced vital capacity (FVC), forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), maximal expiratory flow at 50% of forced vital capacity (MEF50). Unite of measurements: all measurements are taken as a percentage from predicted.

    Time frame: Baseline and after 8 weeks (post-intervention)

  2. Pulmonary function test (Maximal inspiratory flow at 50% of FVC (MIF50))

    Pulmonary function test will be performed using a MasterScreen Pneumo spirometer (Jaeger). This examination is non-invasive and performed in accordance with ATS and ERS criteria. Maximal inspiratory flow at 50% of FVC (MIF50) is expressed in litres per second (l/s).

    Time frame: Baseline and after 8 weeks (post-intervention)

  3. Pulmonary function test (MEF50/MIF50 ratio)

    Pulmonary function test will be performed using a MasterScreen Pneumo spirometer (Jaeger). This examination is non-invasive and performed in accordance with ATS and ERS criteria. The MEF50/MIF50 ratio is a dimensionless value (because in this case the MEF50 value is expressed in l/s, similarly to MIF50). This indicator assesses airway patency. It is mainly used for the diagnosis and differentiation of upper airway stenosis.

    Time frame: Baseline and after 8 weeks (post-intervention)

  4. Measurement of maximal inspiratory and expiratory pressure

    Respiratory muscle strength will be assessed by measuring maximal inspiratory and expiratory pressure. The test is non-invasive and will be performed using a pneumatic adapter connected to the tachometer of the device used for pulmonary function testing. The assessment will be conducted in accordance with ATS/ERS guidelines; following the recommended procedure, 5 to 10 measurements will be taken, from which the three highest values will be selected. Based on the results of this test, the training parameters for the planned intervention will be determined.

    Time frame: Baseline and after 8 weeks (post-intervention)

  5. Forced oscillation technique (FOT)

    To provide information on the mechanical and elastic properties of the respiratory system, the forced oscillation technique (FOT) will be performed. For this purpose, the Resmon Pro V3 device (MGC Diagnostics®) will be used, employing the built-in pediatric mode that applies an 8 Hz signal frequency. The main parameters analyzed will be resistance (Rrs) and reactance (Xrs).

    Time frame: Baseline and after 8 weeks (post-intervention)

  6. Six-minute walk test (6MWT)

    This test will be used to assess cardiorespiratory fitness. The examination will be conducted in accordance with the American Thoracic Society guidelines for this test. The parameter analyzed will be the distance covered by the participants.

    Time frame: Baseline and after 8 weeks (post-intervention)

  7. Isokinetic dynamometry (Peak torque)

    Isokinetic dynamometry using the Biodex Multi-Joint System will be employed to assess the participants' ability to maintain postural stability in different planes under static and isokinetic conditions. Assessed muscle groups responsible for trunk stabilization: trunk flexors (abdominal muscles) and trunk extensors (back muscles). The evaluated parameter, peak torque, represents the maximum recorded torque produced by the analyzed muscle group at a specified angular velocity, expressed in newton-meters (N·m). Measurements will consist of performing trunk flexion and extension as quickly as possible with maximal force at two angular velocities. A warm-up will be conducted prior to testing. Five maximal trials will be performed, with rest periods between trials. During the trials, participants will be verbally encouraged to exert maximal effort.

    Time frame: Baseline and after 8 weeks (post-intervention)

  8. Isokinetic dynamometry (Total work)

    Isokinetic dynamometry using the Biodex Multi-Joint System will be employed to assess the participants' ability to maintain postural stability in different planes under static and isokinetic conditions. Assessed muscle groups responsible for trunk stabilization: trunk flexors (abdominal muscles) and trunk extensors (back muscles). Total work is the work performed by the muscles throughout all movements executed during the task. It also allows for the assessment of muscle endurance. This parameter is expressed in joules (J). Measurements will consist of performing trunk flexion and extension as quickly as possible with maximal force at two angular velocities. A warm-up will be conducted prior to testing. Five maximal trials will be performed, with rest periods between trials. During the trials, participants will be verbally encouraged to exert maximal effort.

    Time frame: Baseline and after 8 weeks (post-intervention)

  9. Isokinetic dynamometry (Average power)

    Isokinetic dynamometry using the Biodex Multi-Joint System will be employed to assess the participants' ability to maintain postural stability in different planes under static and isokinetic conditions. Assessed muscle groups responsible for trunk stabilization: trunk flexors (abdominal muscles) and trunk extensors (back muscles). Average power is a parameter calculated by dividing the work performed during a single repetition by the duration of the movement. Its values are expressed in watts (W). Measurements will consist of performing trunk flexion and extension as quickly as possible with maximal force at two angular velocities. A warm-up will be conducted prior to testing. Five maximal trials will be performed, with rest periods between trials. During the trials, participants will be verbally encouraged to exert maximal effort.

    Time frame: Baseline and after 8 weeks (post-intervention)

Secondary outcomes

  1. Physical activity

    Physical activity levels will be assessed using the PAQ-C (Physical Activity Questionnaire for Children) or PAQ-A (Physical Activity Questionnaire for Adolescents). This questionnaire gathers information on the frequency and intensity of physical activities, including sports, outdoor play, and other forms of exercise. Higher scores indicate greater levels of physical activity.

    Time frame: Before intervention

07

Study locations

2 of 2 sites recruiting
  • Centrum Skolioz- Centrum Diagnostyczno-Rehabilitacyjne Promyk Słońca
    Wroclaw, Lower Silesian Voivodeship 50-088, Poland
    Recruiting
  • Wroclaw University of Health and Sport Sciences
    Wroclaw, Lower Silesian Voivodeship 51-612, Poland
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2025 (actual). Primary completion is estimated for May 2027, 19 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2025
First posted
Sep 17, 2025
StartActual
Oct 13, 2025
Primary completionEst.
May 2027
CompletionEst.
Jul 2027
Last update
Dec 5, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07177430
Lead sponsor
Wroclaw University of Health and Sport Sciences
Responsible party
Aleksandra Grudzińska (MSc, Wroclaw University of Health and Sport Sciences) — Principal investigator
First posted
Sep 17, 2025
Start date
Oct 13, 2025
Primary completion
May 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Dec 5, 2025

Study contacts

Aleksandra Grudzińska, MSc
Contact
aleksandra.grudzinska@awf.wroc.pl
503676949, +48
Krystyna Rożek-Piechura, Professor
study director · Wroclaw University of Health and Sport Sciences, Poland
Aleksandra Grudzińska, MSc
principal investigator · Wroclaw University of Health and Sport Sciences, Poland
Elżbieta Piątek-Krzywicka, PhD
principal investigator · Wroclaw University of Health and Sport Sciences, Poland
Anna Badowska, MD
principal investigator
Jerzy R Piechura, PhD
principal investigator · Wroclaw University of Health and Sport Sciences, Poland
Paulina Okrzymowska, PhD
principal investigator · Wroclaw University of Health and Sport Sciences, Poland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion